Abstract
Fluvoxamine, a selective serotonin re uptake inhibitor, is used to treat depression. The aim of present study was to evaluate fluvoxamine in acute (egg albumin-induced inflammation) and chronic inflammatory rat models (formaldehyde and complete Freund’s adjuvant (CFA)-induced arthritis). Fluvoxamine showed highly significant (p<0.001) protective effect at dose of 50 mg/kg orally with percentage suppression 21.3% as compared to disease control group in acute model. Likewise, formaldehyde-induced arthritic experiment confirmed the significant (p<0.001) anti-arthritic behavior, showed by fluvoxamine (50 mg/kg orally) throughout the study. Moreover, In CFA-induced model, the higher dose (fluvoxamine 50 mg/kg) exhibited highly significant (p<0.001) decrease in paw thickness and arthritic score with significant increase in weight of animals from 123.8± 1.934 g to 130.2± 1.655 g, significantly decreased the level of RF and CRP to level of 12.0±0.707 and 11.40±0.50 respectively and restoration of SOD, CAT (69.8±1.5, 72.0±1.4 respectively). Furthermore, the level of TNF-α, PGE2, and IL-1β (147.0±2.0, 406.8±2.5, and 93.8±1.3 respectively) in arthritic animals was reduced to significant (p<0.001) level (53.8±1.3, 205±3.6, and 42.0±1.4 respectively) after treatment with fluvoxamine. Furthermore, molecular docking of fluvoxamine against TNF-α, PGE2, and IL-1β protein targets showed good binding energies which hereby from computational studies proves our compound anti-inflammatory potential. In addition, absorption, distribution, metabolism, excretion, and toxicity (ADMET) studies reveled that fluvoxamine has very good pharmacokinetic profile with no specific hepatic toxicity and good absorption level. In addition, the skin sensitization test in vitro human cell line activation test (h-CLAT) and KeratinoSens have revealed that isolated flavone is not skin sensitive with confidence score of 59.6% and 91.6%. The current findings validated the anti-arthritic potential of fluvoxamine but it should be recommended for clinical investigation in future research.
Similar content being viewed by others
Data availability
Not applicable.
References
Abbott R, Whear R, Nikolaou V, Bethel A, Coon JT, Stein K, Dickens C (2015) Tumour necrosis factor-α inhibitor therapy in chronic physical illness: a systematic review and meta-analysis of the effect on depression and anxiety. J Psychosom Res 79:175–184
Ahsan H, Haider I, Mushtaq MN, Qaisar MN, Naqvi F, Asif A (2021a) Pharmacological support to anti-arthritic prospective of physostigmine: a new approach. Inflammopharmacology 29(4):1119–1129 1-11
Ahsan H, Irfan HM, Jahan S, Shahzad M, Asim MH (2021b) Potential of ephedrine to suppress the gene expression of TNF-α, IL-1β, IL-6 and PGE2: a novel approach towards management of rheumatoid arthritis. Life Sci 282:119825
Akindele AJ, Oladimeji-Salami JA, Usuwah BA (2015) Antinociceptive and anti-inflammatory activities of Telfairia occidentalis hydroethanolic leaf extract (Cucurbitaceae). J Med Food 18:1157–1163
Almutairi KB, Nossent JC, Preen DB, Keen HI, Inderjeeth CA (2021) The prevalence of rheumatoid arthritis: a systematic review of population-based studies. J Rheumatol 48:669–676
Ben IO, Etim OE, Udo NM (2016) Anti-inflammatory effects of Napoleona imperialis P. Beauv.(Lecythidaceae) on rat model of inflammation. Indian J Health Sci Biomed Res (KLEU) 9:89
Bose M, Chakraborty M, Bhattacharya S, Bhattacharjee P, Mandal S, Kar M, Mishra R (2014) Suppression of NF-κ B p65 nuclear translocation and tumor necrosis factor-α by Pongamia pinnata seed extract in adjuvant-induced arthritis. J Immunotoxicol 11:222–230
Chen Y, Tian Y, Gao Y, Wu F, Luo X, Ju X, Liu G (2020) In silico design of novel HIV-1 NNRTIs based on combined modeling studies of dihydrofuro [3, 4-d] pyrimidines. Front Chem 8:164
Chen L, Huang Y, Yu X et al (2021) Corynoxine protects dopaminergic neurons through inducing autophagy and diminishing neuroinflammation in rotenone-induced animal models of Parkinson’s disease. Front Pharmacol 12:642900. https://doi.org/10.3389/fphar.2021.642900
Cruz JV et al (2018) Computational design of new protein kinase 2 inhibitors for the treatment of inflammatory diseases using QSAR, pharmacophore-structure-based virtual screening, and molecular dynamics. J Mol Model 24:1–16
Daina A, Michielin O, Zoete V (2017) SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 7:1–13
Dallé E, Daniels WM, Mabandla MV (2017) Fluvoxamine maleate normalizes striatal neuronal inflammatory cytokine activity in a Parkinsonian rat model associated with depression. Behav Brain Res 316:189–196
Dionisie V, Filip GA, Manea MC, Manea M, Riga S (2020) The anti-inflammatory role of SSRI and SNRI in the treatment of depression: a review of human and rodent research studies. Inflammopharmacology 29(1):75–90 1-16
Ferro F, Elefante E, Luciano N, Talarico R, Todoerti M (2017) One year in review 2017: novelties in the treatment of rheumatoid arthritis. Clin Exp Rheumatol 35:721–734
Gautam RK, Sharma S, Sharma K, Gupta G (2018) Evaluation of antiarthritic activity of butanol fraction of Punica granatum linn. Rind extract against freund’s complete adjuvant-induced arthritis in rats. J Environ Pathol Toxicol Oncol 37:53–62
Hajhashemi V, Sadeghi H, Minaiyan M, Movahedian A, Talebi A (2011) Effect of fluvoxamine on carrageenan-induced paw edema in rats evaluation of the action sites. Iran J Pharm Res: IJPR 10:611
Hassan SS, Muhammad I, Abbas SQ, Hassan M, Majid M, Jin HZ, Bungau S (2021) Stress driven discovery of natural products from actinobacteria with anti-oxidant and cytotoxic activities including docking and admet properties. Int J Mol Sci 22(21):11432
Hodes GE, Ménard C, Russo SJ (2016) Integrating Interleukin-6 into depression diagnosis and treatment. Neurobiol Stress 4:15–22
Jalalpure SS, Mandavkar YD, Khalure PR, Shinde GS, Shelar PA, Shah AS (2011) Antiarthritic activity of various extracts of Mesua ferrea Linn. seed. J Ethnopharmacol 138:700–704
Khalid M, Alqarni MH, Foudah AI, Akhtar J, Shoaib A, Alam P (2020) Evaluation of free radical scavenging potential of different bioactive fractions present in Boerhavia diffusa Linn. root extract: an in-vitro approach. J Pharm Res Int 32:99–107
Mahmood F, Khan JA, Mahnashi MH, Jan MS, Javed MA, Rashid U, Sadiq A, Hassan SS, Bungau S (2022) Anti-inflammatory, analgesic and antioxidant potential of new (2 S, 3 S)-2-(4-isopropylbenzyl)-2-methyl-4-nitro-3-phenylbutanals and their Corresponding carboxylic acids through in vitro, in silico and in vivo studies. Molecules. 27(13):4068
Majid M, Farhan A, Asad MI, Khan MR, Hassan SS, Haq IU, Bungau S (2022) An extensive pharmacological evaluation of new anti-cancer triterpenoid (nummularic acid) from ipomoea batatas through in vitro, in silico, and in vivo studies. Molecules. 27(8):2474
Manan M, Saleem U, Akash MSH, Qasim M, Hayat M, Raza Z, Ahmad B (2020) Antiarthritic potential of comprehensively standardized extract of alternanthera bettzickiana: in vitro and in vivo studies. ACS Omega 5:19478–19496
Qasim S et al (2021) Appraisal of the antiarthritic potential of prazosin via inhibition of proinflammatory cytokine TNF-α: a key player in rheumatoid arthritis. ACS Omega 6:2379–2388
Rajendran R, Krishnakumar E (2010) Anti-arthritic activity of Premna serratifolia Linn., wood against adjuvant induced arthritis. Avicenna J Med Biotechnol 2:101
Ren M, Tang Q, Chen F, Xing X, Huang Y, Tan X (2017) Mahuang Fuzi Xixin decoction attenuates Th1 and Th2 responses in the treatment of ovalbumin-induced allergic inflammation in a rat model of allergic rhinitis. J Immunol Res 2017:8254324
Saleem A, Saleem M, Akhtar MF, Shahzad M, Jahan S (2020) Moringa rivae leaf extracts attenuate complete Freund’s adjuvant-induced arthritis in Wistar rats via modulation of inflammatory and oxidative stress biomarkers. Inflammopharmacology 28:139–151
Sowjanya R, Shankar M, Sireesha B, Naik EA, Yudharaj P, Priyadarshini RJ (2017) An overview on inflammation and plant havinganti inflammatory activity. Int J Phytopharm Res 7:25–32
Thite AT, Patil RR, Naik SR (2014) Anti-arthritic activity profile of methanolic extract of Ficus bengalensis: comparison with some clinically effective drugs. Biomed Aging Pathol 4:207–217
Tiwari R, Chanda S, Maliaraman U, Singh M, Agarwal S (2021) Anti-inflammatory and anti-arthritic potential of standardized extract of Clerodendrum serratum (L.). Moon Front Pharmacol 12:429
ul Hassan SS, Zhang W-D, Jin H-z, Basha SH, Priya SS (2022a) In-silico anti-inflammatory potential of guaiane dimers from Xylopia vielana targeting COX-2. J Biomol Struct Dyn 40:484–498
ul Hassan SS, Qamar Abbas S, Ali F et al (2022b) A comprehensive in silico exploration of pharmacological properties, bioactivities, molecular docking, and anticancer potential of Vieloplain F from Xylopia vielana Targeting B-Raf Kinase. Molecules 27:917
Wang D, Zhao R, Qu Y-Y et al (2018) Colonic lysine homocysteinylation induced by high-fat diet suppresses DNA damage repair. Cell Rep 25:398–412.e6. https://doi.org/10.1016/j.celrep.2018.09.022
Wang X-H, Xu S, Zhou X-Y et al (2021) Low chorionic villous succinate accumulation associates with recurrent spontaneous abortion risk. Nat Commun 12:3428. https://doi.org/10.1038/s41467-021-23827-0
Zhang C (2021) Flare-up of cytokines in rheumatoid arthritis and their role in triggering depression: shared common function and their possible applications in treatment. Biomed Rep 14:1
Zhang X, Liu L, Chen W-C et al (2022) Gestational leucylation suppresses embryonic T-box transcription factor 5 signal and causes congenital heart disease. Adv Sci (Weinheim, Baden-Wurttemberg, Germany) 9:e2201034. https://doi.org/10.1002/advs.202201034
Zhao X, Kim Y-R, Min Y, Zhao Y, Do K, Son Y-O (2021) Natural plant extracts and compounds for rheumatoid arthritis therapy. Medicina 57:266
Zheng C-J et al (2014) Therapeutic effects of standardized Vitex negundo seeds extract on complete Freund's adjuvant induced arthritis in rats. Phytomedicine 21:838–846
Acknowledgements
The authors would like to acknowledge the Higher Education Commission of Pakistan and University of Sargodha, Pakistan, for providing the facilities to conduct research.
Author information
Authors and Affiliations
Contributions
H. Ahsan and M. Ayub have done the experiments and written the original draft. H. M. Irfan and M. Saleem have rechecked the manuscript for any errors. I. Anjum and S. Q. Abbas have analyzed the data. I. Haider and A. Asif have done the in vitro studies. H. A and S. S. U. H have designed and supervised an experiment. I.A revised the manuscript according to reviewer’s comments and prepared the response letter.
Corresponding author
Ethics declarations
Ethics approval
Not applicable.
Consent to participate
Not applicable.
Consent for publication
All the authors have approved the manuscript for publication.
Competing interests
The authors declare no competing interests.
Additional information
Responsible Editor: Mohamed M. Abdel-Daim
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Ahsan, H., Ayub, M., Irfan, H.M. et al. Tumor necrosis factor-alpha, prostaglandin-E2 and interleukin-1β targeted anti-arthritic potential of fluvoxamine: drug repurposing. Environ Sci Pollut Res 30, 14580–14591 (2023). https://doi.org/10.1007/s11356-022-23142-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11356-022-23142-1